Klotho Neurosciences Files 8-K on Shareholder Votes & Financials
Ticker: GRMLW · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1907223
Sentiment: neutral
Topics: corporate-action, financials, filing
Related Tickers: KLTO
TL;DR
Klotho Neurosciences (KLTO) filed an 8-K covering shareholder votes and financials. Stay tuned for updates.
AI Summary
Klotho Neurosciences, Inc. filed an 8-K on May 28, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The company, formerly known as ANEW Medical, Inc. and Redwoods Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates important corporate actions and financial reporting, which are crucial for investors to understand the company's current status and governance.
Risk Assessment
Risk Level: low — This is a routine filing reporting on corporate actions and financial statements, not indicating any immediate material adverse events.
Key Players & Entities
- Klotho Neurosciences, Inc. (company) — Registrant
- ANEW Medical, Inc. (company) — Former Company Name
- Redwoods Acquisition Corp. (company) — Former Company Name
- May 28, 2025 (date) — Date of earliest event reported
- 001-41340 (other) — SEC File Number
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Klotho Neurosciences, Inc.?
Klotho Neurosciences, Inc. operates in the Biological Products sector, specifically 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
When did the company change its name from ANEW Medical, Inc.?
The company's name was changed from ANEW Medical, Inc. on June 24, 2024.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
What is the business address of Klotho Neurosciences, Inc.?
The business address is 1115 Broadway, 12th Floor, New York, NY 10010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Klotho Neurosciences, Inc. (GRMLW).